Stocks kicked off a pivotal week on an upbeat note, boosted by some blue-chip mergers and acquisitions news and a buoyant reading on consumer expectations.
Mostly, however, Monday was a "wait-and-see" session. After all, tomorrow's critical reading on inflation and an interest rate announcement from the Federal Reserve later this week are certain to shape where stocks go next.
The best Dow dividend stocks never go out of style, and on Monday two of them contributed to a big day for M&A news. Amgen (AMGN), which deserves a place in just about any portfolio of top biotech stocks, struck an agreement to buy Horizon Therapeutics (HZNP) for $28.3 billion, including debt. The biggest healthcare deal of 2022 gives Amgen control of Horizon’s treatments for rare autoimmune and inflammatory diseases, including Tepezza, a blockbuster drug for thyroid eye disease.
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Meanwhile, Dow stock Microsoft (MSFT), which routinely ranks as a top stock pick for billionaires and hedge funds alike, struck a 10-year partnership deal with London Stock Exchange Group (LNSTY). The cloud-computing giant, which acquired a 4% stake in the bourse operator, will provide LSE with next-generation infrastructure, data and analytics.
In economic news, a survey by the Federal Reserve Bank of New York showed that regular folks are feeling better about both the future path of inflation and income growth. Consumers' expectations for inflation over the next one, three and five years decreased smartly, the NY Fed reported. At the same time, expectations for income growth reached a series high.
At the end of the day, markets finished the session with broad-based gains. The blue-chip Dow Jones Industrial Average added 1.6% to finish at 34,004, while the broader S&P 500 rose 1.4% to close at 3,990. The tech-heavy Nasdaq Composite gained 1.3% to reach 11,143.
November's Inflation Report: What to Expect
All eyes are on the last inflation report of 2022, slated for release before Tuesday's opening bell – and just a day before the Federal Reserve's final interest rate decision of the year.
A nasty upside surprise in CPI could complicate the central bank's calculus, and even send stocks into a tizzy. To get a sense of what the experts think about tomorrow's inflation report, have a look at what economists, strategists and other market pros have to say about the pending CPI print.
-
Think Twice Before Getting a Credit Card Cash AdvanceA credit card cash advance can be a quick solution when you need emergency help with money. But you'll pay for the convenience with high interest and fees.
-
What is AI Worth to the Economy?The Letter Spending on AI is already boosting GDP, but will the massive outlays being poured into the technology deliver faster economic growth in the long run?
-
If You'd Put $1,000 Into UnitedHealth Group Stock 20 Years Ago, Here's What You'd Have TodayUNH stock was a massive market beater for ages – until it wasn't.
-
What Tariffs Mean for Your Sector ExposureNew, higher and changing tariffs will ripple through the economy and into share prices for many quarters to come.
-
How to Invest for a Fall Interest Rate Cut by the FedA lot can happen between now and then, but the probability the Fed cuts interest rates in September is back above 80%.
-
Are Buffett and Berkshire About to Bail on Kraft Heinz Stock?Warren Buffett and Berkshire Hathaway own a lot of Kraft Heinz stock, so what happens when they decide to sell KHC?
-
How the Stock Market Performed in the First 6 Months of Trump's Second TermSix months after President Donald Trump's inauguration, take a look at how the stock market has performed.
-
If You'd Put $1,000 Into Berkshire Hathaway Stock 20 Years Ago, Here's What You'd Have TodayBerkshire Hathaway is a long-time market beater, but the easy money in BRK.B has already been made.
-
If You'd Put $1,000 Into Procter & Gamble Stock 20 Years Ago, Here's What You'd Have TodayProcter & Gamble stock is a dependable dividend grower, but a disappointing long-term holding.
-
My Three-Day Rule for Investing: And If it Applies NowStock Market I've seen a lot in my career. Here's what I see now in the stock market.
